Healthcare provider profile · identity verified

Kavitha Nutakki, MD

Internal Medicine · MILLBURY, MA · NPI 1639639909

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	307	98
Lisinopril	Lisinopril	284	86
Rosuvastatin Calcium	Rosuvastatin Calcium	216	63
Amlodipine Besylate	Amlodipine Besylate	184	57
Losartan Potassium	Losartan Potassium	180	52
Gabapentin	Gabapentin	170	52
Hydrochlorothiazide	Hydrochlorothiazide	166	49
Levothyroxine Sodium	Levothyroxine Sodium	163	52
Albuterol Sulfate Hfa	Albuterol Sulfate	149	38
Omeprazole	Omeprazole	140	48
Metoprolol Succinate	Metoprolol Succinate	105	37
Simvastatin	Simvastatin	69	20
Tamsulosin Hcl	Tamsulosin Hcl	69	23
Metformin Hcl	Metformin Hcl	65	22
Furosemide	Furosemide	64	28
Carvedilol	Carvedilol	62	17
Duloxetine Hcl	Duloxetine Hcl	60	13
Trazodone Hcl	Trazodone Hcl	52	20
Sertraline Hcl	Sertraline Hcl	49	14
Pantoprazole Sodium	Pantoprazole Sodium	48	13
Potassium Chloride	Potassium Chloride	47	17
Pravastatin Sodium	Pravastatin Sodium	47	13
Buspirone Hcl	Buspirone Hcl	43	11
Escitalopram Oxalate	Escitalopram Oxalate	43	13
Famotidine	Famotidine	42	16
Celecoxib	Celecoxib	39	suppressed
Fluticasone Propionate	Fluticasone Propionate	39	17
Tizanidine Hcl	Tizanidine Hcl	39	11
Azithromycin	Azithromycin	36	31
Finasteride	Finasteride	36	12
Prednisone	Prednisone	36	26
Sumatriptan Succinate	Sumatriptan Succinate	33	suppressed
Allopurinol	Allopurinol	32	suppressed
Atenolol	Atenolol	31	suppressed
Wixela Inhub	Fluticasone Propion/Salmeterol	31	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	30	suppressed
Alendronate Sodium	Alendronate Sodium	29	14
Ibuprofen	Ibuprofen	29	suppressed
Ezetimibe	Ezetimibe	28	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	27	12
Eliquis	Apixaban	26	suppressed
Metformin Hcl Er	Metformin Hcl	26	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	25	suppressed
Bupropion Xl	Bupropion Hcl	24	suppressed
Montelukast Sodium	Montelukast Sodium	24	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	23	19
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	23	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	20	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	20	suppressed
Mirtazapine	Mirtazapine	20	suppressed
Pregabalin	Pregabalin	20	suppressed
Doxycycline Monohydrate	Doxycycline Monohydrate	19	13
Hydrocortisone	Hydrocortisone	18	15
Metoprolol Tartrate	Metoprolol Tartrate	18	suppressed
Naproxen	Naproxen	18	suppressed
Topiramate	Topiramate	18	suppressed
Clopidogrel	Clopidogrel Bisulfate	17	suppressed
Klor-Con M20	Potassium Chloride	17	suppressed
Levetiracetam	Levetiracetam	17	suppressed
Paroxetine Hcl	Paroxetine Hcl	17	suppressed
Chlorthalidone	Chlorthalidone	16	suppressed
Jardiance	Empagliflozin	16	suppressed
Lamotrigine	Lamotrigine	16	suppressed
Baclofen	Baclofen	15	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	15	suppressed
Valsartan	Valsartan	15	suppressed
Ventolin Hfa	Albuterol Sulfate	15	suppressed
Bupropion Hcl	Bupropion Hcl	14	suppressed
Klor-Con M10	Potassium Chloride	14	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	14	13
Oxybutynin Chloride	Oxybutynin Chloride	14	suppressed
Ozempic	Semaglutide	14	suppressed
Budesonide-Formoterol Fumarate	Budesonide/Formoterol Fumarate	13	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	13	suppressed
Lorazepam	Lorazepam	13	11
Paxlovid	Nirmatrelvir/Ritonavir	13	13
Rizatriptan	Rizatriptan Benzoate	13	suppressed
Spironolactone	Spironolactone	13	suppressed
Warfarin Sodium	Warfarin Sodium	13	suppressed
Citalopram Hbr	Citalopram Hydrobromide	12	suppressed
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	12	suppressed
Irbesartan	Irbesartan	12	suppressed
Labetalol Hcl	Labetalol Hcl	12	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	12	suppressed
Donepezil Hcl	Donepezil Hcl	11	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error